Synergistic effect of ponatinib and epigallocatechin-3-gallate induces apoptosis in chronic myeloid leukemia cells through altering expressions of cell cycle regulatory genes.


GOKER B. , CALISKAN C., CAGLAR H. O. , KAYABASI C., BALCI T., Tepedelen B. E. , ...More

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, vol.19, no.4, pp.992-8, 2014 (Journal Indexed in SCI Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 4
  • Publication Date: 2014
  • Title of Journal : Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • Page Numbers: pp.992-8

Abstract

Purpose: Ponatinib (P) has been used for the treatment of chronic myeloid leukemia (CML) and it is known that inhibition of BCR-ABL fusion protein by ponatinib induces apoptosis of CML cells. Epigallocatechin-3-gallate (EGCG), which is a poly phenol in green tea, induces apoptosis in different types of cancer cells. The purpose of this study was to determine the cytotoxic and apoptotic effects of ponatinib and EGCG combination in K562 CML cell line. This study also aimed to detect alterations of the expression levels of cell cycle-regulation related genes after ponatinib and EGCG combination in K562 CML cell line.